Tumor characteristics and clinical outcome of tubular nad mucinous breast carcinomas

Journal of Clinical Oncology

Volumn 17, Issue 5, 1999, Pages 1442-1448

  Diab, Sami G ^a   Clark, Gary M ^a   Osborne, C Kent ^a   Libby, Arlene ^a   Allred, D Craig ^a   Elledge, Richard M ^a  

^a Mays Cancer Center at UT Health San Antonio

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER REGRESSION; CANCER SIZE; CANCER THERAPY; FEMALE; HORMONAL THERAPY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032895974     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.5.1442     Document Type: Article

References (25)

1. McDivitt RW, Boyce W, Gersell D: Tubular carcinoma of the breast: Clinical and pathological observations concerning 135 cases. Am J Surg Pathol 6:401-411, 1982
2. Oberman HA, Fidler WJ Jr: Tubular carcinoma of the breast. Am J Surg Pathol 3:387-395, 1979
3. Komaki K, Sakamoto G, Sugano H, et al:. Mucinous carcinoma of the breast in Japan: A prognostic analysis based on morphologic features. Cancer 61:989-996, 1988
4. Scopsi L, Andreola S, Pilotti S, et al: Mucinous carcinoma of the breast: A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation. Am J Surg Pathol 18:702-711, 1994
5. Northridge ME, Rhoads GG, Wartenberg D, et al: The importance of histologic type on breast cancer survival. J Clin Epidemiol 50:283-290, 1997
6. Clark GM, Dressler LG, Owens MA, et al: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320:627-633, 1989
7. Wenger CR, Beardslee S, Owens MA, et al: DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 28:9-20, 1993
8. Clark GM, Wenger C, Beardslee S, et al: How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer. Cancer 71:2157-2162, 1993
9. Ciocca DR, Fujimura FK, Tandon AK, et al: Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers. J Natl Cancer Inst 84:1279-1282, 1992
10. Clark GM, Osborne CK, Levitt D, et al: Telomerase activity and survival of patients with node-positive breast cancer. J Natl Cancer Inst 89:1874-1881, 1997
11. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
12. Cox DR: Regression models and life-tables. J R Stat Soc B 34:187-220, 1972
13. Rescigno J, Schiff PB: Tubular carcinoma: Analysis of 1623 patients from the SEER database. Breast Cancer Res Treat 46:40, 1997 (abstr 142)
14. Stierer M, Rosen H, Weber R, et al: Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer: Correlation of histopathology and prognostic factors. Ann Surg 218:13-21, 1993
15. Rasmussen BB, Rose C, Christensen IB: prognostic factors in primary mucinous breast carcinoma. Am J Clin Pathol 87:155-160, 1987
16. Wulsin JH, Schreiber JT: Improved prognosis in certain patterns of carcinoma of the breast. Arch Surg 85:791-800, 1962
17. Silverberg SG, Kay S, Chitale AR, et al: Colloid carcinoma of the breast. Am J Clin Pathol 55:355-363, 1971
18. McBoyle MF, Razek HA, Carter JL, et al: Tubular carcinoma of the breast: An institutional review. Am Surg 63:639-644, 1997
19. Helin HJ, Helle MJ, Kallioniemi OP, et al: Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma: Correlation with histopathology and DNA flow cytometry. Cancer 63:1761-1767, 1989
20. Reiner A, Reiner G, Spona J, et al: Histopathologic characterization of human breast cancer in correlation with estrogen receptor status: A comparison of immunocytochemical and biochemical analysis. Cancer 61:1149-1154, 1988
21. Mohammed RH, Lakatua DJ, Haus E, et al: Estrogen and progesterone receptors in human breast cancer: Correlation with histologic subtype and degree of differentiation. Cancer 58:1076-1081, 1986
22. McCarty KS Jr, Barton TK, Fetter BF, et al: Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma. Cancer 46:2851-2858, 1980 (suppl 12)
23. Moran RE, Black MM, Alpert L, et al: Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer. Cancer 54:1586-1590, 1984
24. Feichter GE, Mueller A, Kaufmann M, et al: Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer. Int J Cancer 41:823-828, 1988
25. Libby A, Hilsenbeck SG, Elledge RM, et al: Biologic phenotypes of special-type compared to no-special-type invasive breast cancers. Breast Cancer Res Treat 46:108, 1997 (abstr 461)